A NOVEL PPAR-GAMMA AGONIST, AS002, INDUCES PPAR-GAMMA-ACTIVITY IN ULCERATIVE COLITIS MUCOSA, AND PREVENTS AND REVERSES INFLAMMATION IN DSS COLITIS.

Stéphanie Da Silva  1     Åsa V. Keita  1     Sofie Mohlin  2     Sven Pahlman  3     Ingrid Pahlman     Johan D. Söderholm    
1 Department of Clinical and Experimental Medicine,Faculty of Health Sciences Linköping University,Linköping,Sweden
2 Translational Cancer Research,Cancer Center at Medicon Village,Lund,Sweden
3 Translational Cancer Research,Ca

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing